Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Function Health has secured $53 million in Series A funding, with backing from notable investors including the a16zBioHealth team. The company aims to revolutionize preventative healthcare by collecting over 100 biomarkers from lab tests, surpassing the typical annual physicals. Function Health integrates data from labs, electronic health records (EHRs), and wearables to provide personalized health insights. The company offers robust lab testing twice a year. Co-founder Mark Hyman emphasizes the importance of empowering individuals to take control of their health outside the doctor's office, highlighting the role of AI and extensive health data in achieving this goal.
"Medicine is still in the dark ages." Function co-founder Mark Hyman on the future of preventative healthcare as his company reaches $53 million in Series A funding https://t.co/Y7yOOeSIcK https://t.co/I8KM8YksUF
Integrating extensive personal health data with AI and the world’s health knowledge is the key to living 100 healthy years. @Function is leading this transformation by offering robust lab testing twice a year, covering over 100 biomarkers—far more than traditional annual… https://t.co/ElGF7CtpWD
Consumers are increasingly taking back control of their health and I'm really excited to partner with @a16zBioHealth team to back @function's @drmarkhyman, @swerdlin, @pranithapat, @WeisfeldSeth and @mikenemke for their Series A! https://t.co/suUqtN9Fen